Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Aliskiren Dose Response in Pediatric Hypertension
NCT01150357Phase 3Completed
- Sponsor
- Novartis
- Start
- Jun 2010
- Primary completion
- Aug 2014
- Modality
- Small Molecules
- Countries
- 9
01
Overview
A Phase 3 trial of aliskiren in hypertension (HTN), sponsored by Novartis. Started Jun 2010; status: completed.
02
Drugs
aliskiren
03
Conditions
hypertension (HTN)
Beyond the preview
Go deeper on NCT01150357.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01150357.